SCI-supported treatment starts in Nigeria

The first round of SCI-supported treatment has started in Nigeria as part of a collaboration between SCI and Sightsavers.

The programme will aim to provide 3 million treatments against schistosomiasis and close to 800,000 treatments against soil-transmitted helminth infections for school-age children, in 54 Local Governorate Authorities, across 5 states.  

The implementation of the programme will be supported by the Nigerian Federal Ministry of Health and Sightsavers, with funding from SCI. Addtionally, SCI will provide technical assistance where appropriate.

This is a very exciting project for SCI, as it has been made possible through unrestricted funds acquired through the recommendation of GiveWell, an international charity evaluator. 

SCI’s Programme Manager for Nigeria, Yolisa Nalule, says: “It is a great feeling to be part of the first treatment programme in these states, with an amazing team supporting it. There were no treatments available for these children before this programme and we hope to see positive results in controlling these diseases over time.”

It is anticipated that all treatments will be distributed by the end of August 2017, with a coverage survey to take place soon after, to determine success.

An estimated 28 million people are in need of treatment for schistosomiasis in Nigeria, but only 30% of these individuals are currently being reached. It is hoped that through partnerships such as the one between Sightsavers and SCI, and with the support of donors including USAID, DFID and individuals, the national programme will be able to scale up treatment for NTDs and reach all those affected.